All In Biotech

Free tool

FAERS Monitor: Enbumyst

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 219500 or its brand name (Enbumyst, Bumetanide). Reports on generic versions are filed under their own applications.

Reports

20,456

Serious

15,798

77% of reports

Hospitalization

9,658

Death reported

3,059

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea1,981
  • acute kidney injury1,414
  • fatigue1,340
  • death1,290
  • diarrhoea1,251
  • nausea1,149
  • dizziness1,004
  • headache984
  • pneumonia847
  • hypotension760
  • renal failure745
  • fall735
  • asthenia726
  • chronic kidney disease726
  • pain695

Reports by year received

View as table
YearReports
2004176
2005224
2006205
2007195
2008202
2009209
2010260
2011357
2012446
2013465
2014609
2015931
20161,178
20171,236
20181,430
20191,547
20201,562
20211,172
20221,111
20231,478
20241,886
20252,037
20261,540

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,033,703 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chronic kidney diseaseSignal7269.99.25,772
acute kidney injurySignal1,4149.69.110,835
renal failureSignal7455.85.42,953
hypotensionSignal7603.93.61,650
dyspnoeaSignal1,9813.63.53,820
pneumoniaSignal8472.72.5912
fallSignal7352.32.1530
dizzinessSignal1,0042.12.0568
diarrhoea1,2512.01.9638
asthenia7262.01.9361
fatigue1,3401.81.7465
headache9841.61.5236
death1,2901.51.5254
nausea1,1491.51.4194
pain6951.21.116

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.